Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin

NCT01169779 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

391

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Lixisenatide (AVE0010)
DRUG: Placebo
DEVICE: Pen auto-injector
DRUG: Metformin
DRUG: Sulfonylurea

Sponsor

Sanofi